Functional and structural characteristics in patients with diabetic macular oedema after switching from ranibizumab to aflibercept treatment. Three year results in real world settings

BACKGROUND: Our aim was to examine the long term anatomical and functional outcomes in patients with refractory diabetic macular oedema (DMO) undergoing treatment switch from ranibizumab to aflibercept. METHODS: Retrospective review of patients with DMO undergoing treatment switch from ranibizumab t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sepetis, Anastasios E., Clarke, Holly, Gupta, Bhaskar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973508/
https://www.ncbi.nlm.nih.gov/pubmed/35365223
http://dx.doi.org/10.1186/s40942-022-00373-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973508/
https://www.ncbi.nlm.nih.gov/pubmed/35365223
http://dx.doi.org/10.1186/s40942-022-00373-5

Ejemplares similares